As CRC progresses toward a poorly differentiated state, it is highly likely that TGFβ1+ Treg, through these ligand‐receptor interactions, exerts a profound regulatory influence over CD8+ T cells. This evidence concerns the gene CD8A and colorectal carcinoma.